Tacrolimus Loaded Cationic Liposomes for Dry Eye Treatment

Overview

Journal Front Pharmacol

Date 2022 Feb 21

PMID 35185587

Authors

Xiang Chen

Jicheng Wu

Xueqi Lin

Xingdi Wu

Xuewen Yu

Ben Wang

Wen Xu

Affiliations

Soon will be listed here.

Abstract

Eye drops are ophthalmic formulations routinely used to treat dry eye. However, the low ocular bioavailability is an obvious drawback of eye drops owing to short ocular retention time and weak permeability of the cornea. Herein, to improve the ocular bioavailability of eye drops, a cationic liposome eye drop was constructed and used to treat dry eye. Tacrolimus liposomes exhibit a diameter of around 300 nm and a surface charge of +30 mV. Cationic liposomes could interact with the anionic ocular surface, extending the ocular retention time and improving tacrolimus amount into the cornea. The cationic liposomes notably prolonged the ocular retention time of eye drops, leading to an increased tacrolimus concentration in the ocular surface. The tacrolimus liposomes were also demonstrated to reduce reactive oxygen species and dry eye-related inflammation factors. The use of drug-loaded cationic liposomes is a good formulation in the treatment of ocular disease; the improved ocular retention time and biocompatibility give tremendous scope for application in the treatment of ocular disease, with further work in the area recommended.

Citing Articles

Double Peptide-Functionalized Carboxymethyl Chitosan-Coated Liposomes Loaded with Dexamethasone as a Potential Strategy for Active Targeting Drug Delivery.

Iftode L, Cadinoiu A, Rata D, Atanase L, Vochita G, Radulescu L Int J Mol Sci. 2025; 26(3).

PMID: 39940692 PMC: 11816442. DOI: 10.3390/ijms26030922.

Layer-by-Layer Biopolymer-Coated Deformable Liposomes-In Situ Gel: A Hybrid Strategy for Enhanced Ocular Delivery of Itraconazole: In Vitro and In Vivo Appraisal.

Badran M, Alsubaie A, Bekhit M, Alomrani A, Almomen A Gels. 2025; 11(1).

PMID: 39851990 PMC: 11765087. DOI: 10.3390/gels11010019.

Biomimetic Curcumin-Loaded Liposomes for the Treatment of Dry Eyes and Meibomian Gland Dysfunction: An In Vivo Study.

Baranauskas V, Jaruseviciene R, Grigalavicius M, Galgauskas S, Karabanovas V, Steponkiene S J Clin Med. 2024; 13(21).

PMID: 39518574 PMC: 11546689. DOI: 10.3390/jcm13216436.

Scanning Electron Microscopy (SEM) Evaluation of the Ultrastructural Effects on Conjunctival Epithelial Cells of a New Multiple-Action Artificial Tear Containing Cross-Linked Hyaluronic Acid, Cationic Liposomes and Trehalose.

Troisi M, Prete S, Troisi S, Marasco D, Rinaldi M, Costagliola C Biomedicines. 2024; 12(9).

PMID: 39335459 PMC: 11429469. DOI: 10.3390/biomedicines12091945.

A novel liposomal formulation for ocular delivery of caspofungin: an experimental study by quality by design-based approach.

Macwan M, Paliwal H, Prajapati B Ther Deliv. 2024; 15(9):667-683.

PMID: 39101438 PMC: 11415022. DOI: 10.1080/20415990.2024.2379756.

References

Kayser O, Lemke A, Hernandez-Trejo N . The impact of nanobiotechnology on the development of new drug delivery systems. Curr Pharm Biotechnol. 2005; 6(1):3-5. DOI: 10.2174/1389201053167158. View

Luo L, Nguyen D, Lai J . Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension. Theranostics. 2021; 11(11):5447-5463. PMC: 8039939. DOI: 10.7150/thno.54525. View

Farhadi F, Nayebzadeh N, Badiee A, Arabsalmani M, Hatamipour M, Iranshahi M . A validated H-NMR method for quantitative analysis of DOTAP lipid in nanoliposomes containing soluble Leishmania antigen. J Pharm Biomed Anal. 2020; 194:113809. DOI: 10.1016/j.jpba.2020.113809. View

Stapleton F, Alves M, Bunya V, Jalbert I, Lekhanont K, Malet F . TFOS DEWS II Epidemiology Report. Ocul Surf. 2017; 15(3):334-365. DOI: 10.1016/j.jtos.2017.05.003. View

Li Y, Luo L, Harroun S, Wei S, Unnikrishnan B, Chang H . Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease. Nanoscale. 2019; 11(12):5580-5594. DOI: 10.1039/c9nr00376b. View

Chaiyasan W, Srinivas S, Tiyaboonchai W . Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface. J Ocul Pharmacol Ther. 2013; 29(2):200-7. PMC: 3601816. DOI: 10.1089/jop.2012.0193. View

Wolffsohn J, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K . TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017; 15(3):539-574. DOI: 10.1016/j.jtos.2017.05.001. View

Chen Y, Dana R . Autoimmunity in dry eye disease - An updated review of evidence on effector and memory Th17 cells in disease pathogenicity. Autoimmun Rev. 2021; 20(11):102933. PMC: 8530974. DOI: 10.1016/j.autrev.2021.102933. View

Meloni M, Pauly A, De Servi B, Varlet B, Baudouin C . Occludin gene expression as an early in vitro sign for mild eye irritation assessment. Toxicol In Vitro. 2009; 24(1):276-85. DOI: 10.1016/j.tiv.2009.08.016. View

10.

Wei Y, Asbell P . The core mechanism of dry eye disease is inflammation. Eye Contact Lens. 2014; 40(4):248-56. PMC: 4231828. DOI: 10.1097/ICL.0000000000000042. View

11.

Okahara A, Kawazu K . Local toxicity of benzalkonium chloride in ophthalmic solutions following repeated applications. J Toxicol Sci. 2013; 38(4):531-7. DOI: 10.2131/jts.38.531. View

12.

Arvizo R, Miranda O, Thompson M, Pabelick C, Bhattacharya R, Robertson J . Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano Lett. 2010; 10(7):2543-8. PMC: 2925219. DOI: 10.1021/nl101140t. View

13.

Perez-Garmendia R, Lopez de Eguileta Rodriguez A, Ramos-Martinez I, Martinez Zuniga N, Gonzalez-Salinas R, Quiroz-Mercado H . Interplay between Oxidative Stress, Inflammation, and Amyloidosis in the Anterior Segment of the Eye; Its Pathological Implications. Oxid Med Cell Longev. 2020; 2020:6286105. PMC: 7291327. DOI: 10.1155/2020/6286105. View

14.

Steffes V, Murali M, Park Y, Fletcher B, Ewert K, Safinya C . Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies. Biomaterials. 2017; 145:242-255. PMC: 5610109. DOI: 10.1016/j.biomaterials.2017.08.026. View

15.

Han H, Yin Q, Tang X, Yu X, Gao Q, Tang Y . Development of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization. J Mater Chem B. 2020; 8(23):5143-5154. DOI: 10.1039/d0tb00874e. View

16.

Rusnak F, Mertz P . Calcineurin: form and function. Physiol Rev. 2000; 80(4):1483-521. DOI: 10.1152/physrev.2000.80.4.1483. View

17.

Kumar V, Kumar A . Immunological aspects of corneal transplant. Immunol Invest. 2014; 43(8):888-901. DOI: 10.3109/08820139.2014.910024. View

18.

Weng Y, Ma X, Che J, Li C, Liu J, Chen S . Nanomicelle-Assisted Targeted Ocular Delivery with Enhanced Antiinflammatory Efficacy In Vivo. Adv Sci (Weinh). 2018; 5(1):1700455. PMC: 5770669. DOI: 10.1002/advs.201700455. View

19.

Zhang X, Taylor D, Thomas R, Penfold J . Adsorption of polyelectrolyte/surfactant mixtures at the air-water interface: modified poly(ethyleneimine) and sodium dodecyl sulfate. Langmuir. 2011; 27(6):2601-12. DOI: 10.1021/la104698w. View

20.

Tsao Y, Wu W, Chen K, Yeh L, Hwang Y, Hsueh Y . Analysis of aqueous humor total antioxidant capacity and its correlation with corneal endothelial health. Bioeng Transl Med. 2021; 6(2):e10199. PMC: 8126826. DOI: 10.1002/btm2.10199. View